| Literature DB >> 24296045 |
Yoshihito Naito1, Takayuki Terukina2, Silvia Galli3, Yusuke Kozai4, Stefan Vandeweghe5, Tatsuaki Tagami2, Tetsuya Ozeki2, Tetsuo Ichikawa1, Paulo G Coelho6, Ryo Jimbo7.
Abstract
The present study describes the development of a microsphere capsule based on polylactide-co-glycolide (PLGA) loaded with simvastatin that was subsequently incorporated into synthetic bone cement. The osteogenic effect of simvastatin-loaded bone cement was in a critical sized defect in vivo to test the hypothesis the biologic response would be different depending on the dosage of simvastatin applied to bone cement. Our results showed that simvastatin loaded PLGA microspheres can be successfully obtained through O/W emulsion/solvent evaporation method with appropriate morphologic characteristics and high encapsulation efficiency for incorporation in bone cements. The biodegradable characteristic of the microspheres successfully presented a slow release and the duration of the release lasted for more than 1 month. The in vivo experiment revealed that the microspheres containing simvastatin significantly enhanced bone formation in the rabbit calvaria critical size defect.Entities:
Keywords: Bone substitutions; Critical sized defect; PLGA microspheres; Simvastatin
Mesh:
Substances:
Year: 2013 PMID: 24296045 DOI: 10.1016/j.ijpharm.2013.11.046
Source DB: PubMed Journal: Int J Pharm ISSN: 0378-5173 Impact factor: 5.875